Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | OGT | O15294 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RGS12 | O14924 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31114 | 0.69 | — | — | |
| SCHEMBL10988745 | 0.67 | TSHR (0.39) | TSHRKDM4EOGTUSP2MAPT | |
| SCHEMBL133284 | 0.67 | HSD17B10 (0.39) | TSHRKDM4EOGTUSP2MAPT | |
| SCHEMBL9211477 | 0.67 | TSHR (0.39) | TSHRKDM4EOGTUSP2MAPT | |
| SCHEMBL131371 | 0.67 | TSHR (0.39) | TSHRKDM4EOGTUSP2MAPT | |
| Water SCHEMBL11883570 | 0.65 | HSD17B10 (0.38) | TSHRKDM4EOGTUSP2MAPT | |
| SCHEMBL8647881 | 0.65 | TSHR (0.38) | TSHRKDM4EOGTUSP2MAPT | |
| SCHEMBL17294184 | 0.65 | TSHR (0.50) | TSHRKDM4EOGTUSP2MAPT | |
| SCHEMBL5842299 | 0.65 | — | — | |
| SCHEMBL2873513 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104127469-A | New application of olive leaf crude extract and tumor therapeutic drug combined kit thereof | SHANGHAI YUXIAN MEDICAL TECHNOLOGY CO LTD | 2014-11-05 | — | — | CN | claimed |
| CN-1923173-A | Anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2007-03-07 | — | — | CN | claimed |
| CN-1857723-A | Slow released anticancer medicine preparation with both amrubicin and its synergist | KANGQUAN MEDICINE SCI TECH CO (CN) | 2006-11-08 | — | — | CN | claimed |
| CN-1634584-A | Anti-cancer medicine composition containing antimetabolite | SHANDONG LANJIN BIOENGINEERING (CN) | 2005-07-06 | — | — | CN | claimed |
| CN-104127469-A | New application of olive leaf crude extract and tumor therapeutic drug combined kit thereof | SHANGHAI YUXIAN MEDICAL TECHNOLOGY CO LTD | 2014-11-05 | — | — | CN | disclosed |
| CN-101244272-B | Anti-solid tumors pharmaceutical combination containing topological enzyme inhibitor | SHANDONG LANJIN BIOENGINEERING CO LTD | 2010-07-14 | — | — | CN | disclosed |
| CN-1927175-B | Compound recipe anticancer slow release injection comprising tetrazole violet | JINAN SHUAIHUA PHARMACEUTICAL TECHNOLOGY CO LTD | 2010-05-19 | — | — | CN | disclosed |
| CN-1923173-B | Anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof | JINAN KANGQUAN PHARMACEUTICAL CO LTD | 2010-05-19 | — | — | CN | disclosed |
| US-7666977-B2 | Poly(carbonate-co-urea) copolymers and melt transesterification method of preparing these copolymers | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-02-23 | — | — | US | disclosed |
| US-7557175-B2 | Poly(carbonate-co-urea) copolymers and melt transesterification method of preparing these copolymers | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-07-07 | — | — | US | disclosed |
| CN-100500212-C | Anti entity tumour medicinal composition | SHANDONG LANJIN BIOLOG ENGINEE (CN) | 2009-06-17 | — | — | CN | disclosed |
| CN-100500218-C | Anti tumour medicinal composition | SHANDONG LANJIN BIOLOG ENGINEE (CN) | 2009-06-17 | — | — | CN | disclosed |
| CN-1686554-A | Anti entity tumour medicinal composition containing platinum compound | SHANDONG LANJIN BIOLOG ENGINEE (CN) | 2005-10-26 | — | — | CN | disclosed |
| CN-1686552-A | Anti-solid tumor pharmaceutical composition containing topoisomerase inhibitor | SHANDONG LANJIN BIOLOG ENGINEE (CN) | 2005-10-26 | — | — | CN | disclosed |
| CN-1686555-A | Anti entity tumour medicinal composition containing tetrazine kind compound | SHANDONG LANJIN BIOLOG ENGINEE (CN) | 2005-10-26 | — | — | CN | disclosed |
| CN-1686553-A | Anti entity tumour medicinal composition | SHANDONG LANJIN BIOLOG ENGINEE (CN) | 2005-10-26 | — | — | CN | disclosed |
| CN-1679950-A | Anticarcinogenic internal implant agent | LANJIN BIOLOG ENGINEERING CO L (CN) | 2005-10-12 | — | — | CN | disclosed |
| CN-1679944-A | Anticarcinogen composition | LANJIN BIOLOG ENGINEERING CO L (CN) | 2005-10-12 | — | — | CN | disclosed |
| CN-1634584-A | Anti-cancer medicine composition containing antimetabolite | SHANDONG LANJIN BIOENGINEERING (CN) | 2005-07-06 | — | — | CN | disclosed |
| CN-1634586-A | Anti-cancer medicine composition | SHANDONG LANJIN BIOENGINEERING (CN) | 2005-07-06 | — | — | CN | disclosed |